Data from one-year trial on long-term safety, efficacy, and quality of life in advanced Parkinson's disease patients using levodopa-carbidopa intestinal gel has been released by researchers, suggesting that it may be an effective long term treatment for the illness.
from News -- ScienceDaily http://ift.tt/1C1Q1Q3 via Karis World
from News -- ScienceDaily http://ift.tt/1C1Q1Q3 via Karis World
No comments:
Post a Comment